INS and cancer: Interestingly, it was observed that the Matsuda insulin resistance index, which was calculated from post-challenge insulin and glucose levels, significantly predicted cancer, whereas the insulin resistance index HOMA_IR calculated from fasting insulin and glucose levels was not associated with the risk of cancer.